Literature DB >> 7920015

Eosinophil peroxidase differs from neutrophil myeloperoxidase in its ability to bind antineutrophil cytoplasmic antibodies reactive with myeloperoxidase.

S Sullivan1, M A Salapow, R Breen, D H Broide.   

Abstract

The majority of antineutrophil cytoplasmic antibodies (ANCA) in patients with systemic vasculitis (a subset of whom exhibit eosinophilia associated with systemic vasculitis) recognize two neutrophil primary cytoplasmic granule constituents, namely myeloperoxidase (MPO) and proteinase-3. As eosinophil peroxidase (EPO) shares 68% amino acid identity with neutrophil MPO, we have investigated whether serum ANCA reactive with MPO (P-ANCA) also reacts with EPO. In this study we demonstrate that P-ANCA-reactive serum binds to ethanol-fixed neutrophils but not to eosinophils in a perinuclear pattern as assessed by indirect immunofluorescence. In addition, P-ANCA reactive serum did not bind to purified EPO or alter purified EPO function as assessed in a guaiacol assay of EPO activity. These studies suggest that the antigenic epitope recognized by P-ANCA-reactive serum is not determined by the homologous 68% peroxidase sequence shared by neutrophil MPO and EPO.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7920015     DOI: 10.1159/000236817

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  4 in total

1.  Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes.

Authors:  A Scott McCall; Gautam Bhave; Vadim Pedchenko; Jacob Hess; Meghan Free; Dustin J Little; Thomas P Baker; William F Pendergraft; Ronald J Falk; Stephen W Olson; Billy G Hudson
Journal:  J Am Soc Nephrol       Date:  2018-10-02       Impact factor: 10.121

Review 2.  Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.

Authors:  Loïc Raffray; Loïc Guillevin
Journal:  Drugs       Date:  2018-06       Impact factor: 9.546

Review 3.  Pathogenesis and therapeutic interventions for ANCA-associated vasculitis.

Authors:  Daigo Nakazawa; Sakiko Masuda; Utano Tomaru; Akihiro Ishizu
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543

4.  GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.

Authors:  Winston Y Lee; Olga K Weinberg; Geraldine S Pinkus
Journal:  Am J Clin Pathol       Date:  2017-04-01       Impact factor: 2.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.